This review summarizes well-studied serum protein biomarkers (CA19-9, CEA, mucins, and osteopontin) and explores the potential of emerging biomarkers, including exosomes, circulating tumor cells, microRNAs (miRNAs), circulating tumor DNA (ctDNA), and metabolites in pancreatic cancer detection. The gene discussed is CEACAM5; the disease is neoplasm.